Nobivac^® Ducat Questions and Answers

Active immunisation of cats against feline viral rhinotracheitis (feline herpes virus type I) and feline calicivirus infections.

Vaccination reduces clinical signs caused by these viral infections.

The onset of immunity for Feline Calicivirus and Feline Herpes Virus is
4 weeks.

The duration of immunity for Feline Calicivirus and Feline Herpes Virus is
1 year.

Do not use during pregnancy and lactation as the product has not been tested in pregnant and lactating queens.

Nobivac Ducat requires storage in a refrigerator between 2 ^oC and 8 ^oC. Do not freeze. Protect from light.

There are no breed specific contraindications for Nobivac Ducat.

No information is available on the safety and efficacy from the concurrent use of this vaccine with any other, except MSD Animal Health’s vaccine containing rabies antigen, strain Pasteur RIV, where this product and the combined use is authorised.

A decision to use Nobivac Ducat before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.

Yes, as the combined use of Nobivac Ducat and Nobivac FeLV is described on the Nobivac FeLV datasheet and SPC:

"Safety and efficacy data are available which demonstrate that this vaccines can be mixed and administered with cat vaccines of the Nobivac range containing feline calicivirus (F9 strain), feline rhinotracheitis virus (G2620A strain) and/or feline panleucopenia virus (MW-1 or Bristol strain)."

Basic vaccination: Cats from 8 weeks of age onwards should receive two vaccinations with an interval of 3-4 weeks with the second dose from
12 weeks of age. Note that this is most normally undertaken using Nobivac^® Tricat Trio.

Revaccination: An annual booster with Nobivac Ducat or Nobivac^® Tricat depending on the requirement for feline panleucopaenia is recommended.